Article
A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2012
Baldwin R Michael, Owzar Kouros, Zembutsu Hitoshi, Chhibber Aparna, Kubo Michiaki, Jiang Chen, Watson Dorothy, Eclov Rachel J, Mefford Joel, McLeod Howard L, Friedman Paula N, Hudis Clifford A, Winer Eric P, Jorgenson Eric M, Witte John S, Shulman Lawrence N, Nakamura Yusuke, Ratain Mark J, Kroetz Deanna L
Abstract excerpt
PURPOSE: Sensory peripheral neuropathy is a common and sometimes debilitating toxicity associated with paclitaxel therapy. This study aims to identify genetic risk factors for the development of this toxicity. EXPERIMENTAL DESIGN: A prospective pharmacogenetic analysis of patients with primary breast cancer, randomized to the paclitaxel arm of CALGB 40101, was used to identify genetic predictors of the onset and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
